Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries has informed BSE that its Board of Directors will meet on Tuesday, 3 February 2026. The main item on the agenda is to approve and take on record the unaudited financial results of the company for the quarter and nine months ended 31 December 2025. The board may also discuss any other matters as permitted. This is a standard advance intimation filed under Regulation 29 of SEBI LODR rules and contains no financial figures or business updates.
This is a routine procedural filing with no direct impact on shareholders. Investors should watch for the actual Q3FY26 results, which will be released after the board meeting on 3 February 2026, to assess the company's financial performance.